The use of intravenous tissue plasminogen activator (IV-tPA) was initially approved for treatment of acute ischemic stroke (AIS) when administered within 3 h of stroke onset [1] and subsequently was adopted for treatment out to 4.5 h from onset [2]. Here, PLAT is linked to Stroke.